Samsung Electronics, the South Korean tech behemoth, this week claimed that it has designed a new ultrasound image processing engine to offer 3D images of fetuses or of different organs. Dubbed as CrystalLive, the engine was designed in association with Samsung Medison, the medical instrument arm of Samsung, claimed the local media this week.
It is supposed that the engine might assist doctors enhance the accurateness of analysis by spotting possible congenital disorder in fetuses. “We aim to enhance the efficiency and accuracy of diagnosis via the CrystalLive engine and increase the speed of our penetration into university-controlled hospitals, which call for advanced diagnosis,” claimed Samsung Medison to the media in an interview.
Samsung claimed that “WS80A,” its ultrasound device, will employ the CrystalLive solution and will be rolled out in Europe, South Korea, and the U.S. this week. It will enter other markets all over the world even though the planning will rely on approval from local governments.
On a related note, Samsung Research, the highly developed R&D center of Samsung Electronics, this week declared plans to set up 3 AI (artificial intelligence) hubs in Canada, the U.K., and Russia to reinforce the firm’s AI abilities and explore the capability of consumer-centric AI.
Samsung Research has spearhead the newest effort in extending the worldwide AI research abilities of Samsung Electronics and has joined its AI knowledge with the invention of the latest AI hubs. Samsung Research also supervised the production of the new AI hubs last November in Seoul and in January in Silicon Valley. With the inclusion of the 3 new AI hubs, Samsung Research will control 5 AI hubs all over the globe.
Also, by locking worldwide AI experts in its side, Samsung Research aims to extend its number of superior AI scientists to a total of almost 1,000 all over the world by the end of 2020.